Equillium (EQ) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.19, -9.85% vs the prior close of $1.32.
- Volume 466.79K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
EQ slides 9.8% to $1.19, a 6-month low. Closed at $1.19, -9.85% vs the prior close of $1.32. Day range $1.19–$1.35, opened at $1.32.
EQ daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — EQ slides 9.8% to $1.19, a 6-month low
- Closed at $1.19, -9.85% vs the prior close of $1.32. Day range $1.19–$1.35, opened at $1.32.
- Volume was 466.79K shares, 0.8x its 50-day average of 571.92K.
- Price is -39.0% vs its 50-day average ($1.95) and -42.7% vs its 200-day average ($2.08).
- 52-week range $0.76–$3.54; today's close sits at 15% of that range, 66.4% below the 52-week high.
Oct 15, 2026 — EQ rises 1.5% to $1.32
- Closed at $1.32, +1.54% vs the prior close of $1.30. Day range $1.28–$1.38, opened at $1.30.
- Volume was 510.90K shares, 0.9x its 50-day average of 568.15K.
- Price is -32.9% vs its 50-day average ($1.97) and -36.5% vs its 200-day average ($2.08).
- 52-week range $0.76–$3.54; today's close sits at 20% of that range, 62.7% below the 52-week high.
Oct 14, 2026 — EQ dips 1.5% to $1.30, a 6-month low
- Closed at $1.30, -1.52% vs the prior close of $1.32. Day range $1.30–$1.38, opened at $1.32.
- Volume was 263.70K shares, 0.5x its 50-day average of 571.64K — lighter than usual.
- Price is -34.5% vs its 50-day average ($1.99) and -37.5% vs its 200-day average ($2.08).
- 52-week range $0.76–$3.54; today's close sits at 19% of that range, 63.3% below the 52-week high.
Oct 13, 2026 — EQ slides 12.0% to $1.32, a 6-month low
- Closed at $1.32, -12.00% vs the prior close of $1.50. Day range $1.32–$1.50, opened at $1.50.
- Volume was 397.70K shares, 0.7x its 50-day average of 574.16K.
- Price is -34.2% vs its 50-day average ($2.00) and -36.5% vs its 200-day average ($2.08).
- 52-week range $0.76–$3.54; today's close sits at 20% of that range, 62.7% below the 52-week high.
Oct 12, 2026 — EQ jumps 6.4% to $1.50
- Closed at $1.50, +6.38% vs the prior close of $1.41. Day range $1.39–$1.51, opened at $1.42.
- Volume was 383.50K shares, 0.7x its 50-day average of 581.07K.
- Price is -25.8% vs its 50-day average ($2.02) and -27.9% vs its 200-day average ($2.08).
- 52-week range $0.76–$3.54; today's close sits at 27% of that range, 57.6% below the 52-week high.
Oct 9, 2026 — EQ dips 2.1% to $1.41
- Closed at $1.41, -2.08% vs the prior close of $1.44. Day range $1.38–$1.46, opened at $1.45.
- Volume was 522.00K shares, 0.9x its 50-day average of 578.54K.
- Price is -30.8% vs its 50-day average ($2.04) and -32.2% vs its 200-day average ($2.08).
- 52-week range $0.76–$3.54; today's close sits at 23% of that range, 60.2% below the 52-week high.
Oct 8, 2026 — EQ jumps 3.6% to $1.44
- Closed at $1.44, +3.60% vs the prior close of $1.39. Day range $1.34–$1.46, opened at $1.41.
- Volume was 645.00K shares, 1.1x its 50-day average of 573.26K.
- Price is -29.9% vs its 50-day average ($2.05) and -30.8% vs its 200-day average ($2.08).
- 52-week range $0.76–$3.54; today's close sits at 24% of that range, 59.3% below the 52-week high.
Oct 7, 2026 — EQ dips 2.1% to $1.39, a 6-month low
- Closed at $1.39, -2.11% vs the prior close of $1.42. Day range $1.35–$1.43, opened at $1.41.
- Volume was 343.30K shares, 0.6x its 50-day average of 585.72K — lighter than usual.
- Price is -32.9% vs its 50-day average ($2.07) and -33.1% vs its 200-day average ($2.08).
- 52-week range $0.76–$3.54; today's close sits at 23% of that range, 60.7% below the 52-week high.
Oct 6, 2026 — EQ dips 2.1% to $1.42
- Closed at $1.42, -2.07% vs the prior close of $1.45. Day range $1.37–$1.47, opened at $1.39.
- Volume was 393.50K shares, 0.7x its 50-day average of 583.42K.
- Price is -32.1% vs its 50-day average ($2.09) and -31.7% vs its 200-day average ($2.08).
- 52-week range $0.76–$3.54; today's close sits at 24% of that range, 59.9% below the 52-week high.
Oct 5, 2026 — EQ rises 2.8% to $1.45
- Closed at $1.45, +2.84% vs the prior close of $1.41. Day range $1.30–$1.46, opened at $1.37.
- Volume was 793.20K shares, 1.4x its 50-day average of 571.52K.
- Price is -31.3% vs its 50-day average ($2.11) and -30.2% vs its 200-day average ($2.08).
- 52-week range $0.76–$3.54; today's close sits at 25% of that range, 59.0% below the 52-week high.
- SEC filings that day: 8-K.
Oct 2, 2026 — EQ slides 8.4% to $1.41, a 6-month low
- Closed at $1.41, -8.44% vs the prior close of $1.54. Day range $1.38–$1.60, opened at $1.55.
- Volume was 933.80K shares, 1.7x its 50-day average of 558.90K.
- Price is -33.8% vs its 50-day average ($2.13) and -32.0% vs its 200-day average ($2.07).
- 52-week range $0.76–$3.54; today's close sits at 23% of that range, 60.2% below the 52-week high.
EQ latest news & SEC filings
Every SEC filing by or about EQ in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$4.69M (prior year -$5.74M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.04 (prior year -$0.16) (loss narrowed vs Jun 30, 2025)
Aug 13, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 12, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade EQ
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 25, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.97% (largest 12.0%). That is a volatile stock.
- Liquidity: about 705.27K shares (≈$839.28K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.19 vs a range of $0.76–$3.54 (15% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Stephen Connelly sold 30,975 shares on Jun 5, 2026.
- Latest filings: 8-K Oct 5, 2026; 10-Q Aug 13, 2026; 8-K Aug 13, 2026.
- Share count: 63.41M shares outstanding (Aug 7, 2026), +6.6% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
EQ market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.32 | 1.35 | 1.19 | 1.19 | 466.79K |
| Oct 15, 2026 | 1.30 | 1.38 | 1.28 | 1.32 | 510.90K |
| Oct 14, 2026 | 1.32 | 1.38 | 1.30 | 1.30 | 263.70K |
| Oct 13, 2026 | 1.50 | 1.50 | 1.32 | 1.32 | 397.70K |
| Oct 12, 2026 | 1.42 | 1.51 | 1.39 | 1.50 | 383.50K |
| Oct 9, 2026 | 1.45 | 1.46 | 1.38 | 1.41 | 522.00K |
| Oct 8, 2026 | 1.41 | 1.46 | 1.34 | 1.44 | 645.00K |
| Oct 7, 2026 | 1.41 | 1.43 | 1.35 | 1.39 | 343.30K |
| Oct 6, 2026 | 1.39 | 1.47 | 1.37 | 1.42 | 393.50K |
| Oct 5, 2026 | 1.37 | 1.46 | 1.30 | 1.45 | 793.20K |
| Oct 2, 2026 | 1.55 | 1.60 | 1.38 | 1.41 | 933.80K |
| Oct 1, 2026 | 1.67 | 1.67 | 1.53 | 1.54 | 529.00K |
| Sep 30, 2026 | 1.63 | 1.66 | 1.58 | 1.63 | 3.10M |
| Sep 29, 2026 | 1.68 | 1.72 | 1.61 | 1.62 | 316.10K |
| Sep 28, 2026 | 1.65 | 1.72 | 1.63 | 1.68 | 241.70K |
| Sep 25, 2026 | 1.70 | 1.71 | 1.66 | 1.67 | 137.80K |
| Sep 24, 2026 | 1.72 | 1.74 | 1.65 | 1.72 | 280.70K |
| Sep 23, 2026 | 1.91 | 1.91 | 1.69 | 1.75 | 504.50K |
| Sep 22, 2026 | 1.90 | 1.95 | 1.81 | 1.93 | 3.07M |
| Sep 21, 2026 | 1.98 | 1.98 | 1.85 | 1.90 | 266.50K |
About Equillium
Equillium (EQ) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in LA JOLLA, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1746466.
EQ board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Daniel Bradbury | CHAIRMAN | May 29, 2026 |
| Martha J Demski | Director | May 29, 2026 |
| Charles Douglas Mcdermott | Director | May 29, 2026 |
| Mark Pruzanski | Director | May 29, 2026 |
| Bruce D. Steel | Chief Executive Officer | Jan 9, 2026 |
| Barbara Troupin | Director | May 29, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Daniel Bradbury | CHAIRMAN | May 29, 2026 |
| Stephen Connelly | President and CSO | Jun 5, 2026 |
| Bruce D. Steel | Chief Executive Officer | Jan 9, 2026 |
| Penny Tom | Principal Accounting Officer | May 29, 2026 |
| Christine Zedelmayer | Sr. Vice President and COO | Jun 5, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 5, 2026 | Stephen Connelly | Sale | 30,975 | $2.94 |
| Jun 5, 2026 | Stephen Connelly | Sale | 30,975 | $2.94 |
| Jun 5, 2026 | Stephen Connelly | Sale | 30,975 | $2.94 |
| Jun 5, 2026 | Stephen Connelly | Sale | 30,975 | $2.94 |
| Jun 5, 2026 | Christine Zedelmayer | Sale | 14,584 | $2.93 |
| Jun 5, 2026 | Christine Zedelmayer | Sale | 14,584 | $2.93 |
| Jun 5, 2026 | Christine Zedelmayer | Sale | 14,584 | $2.93 |
| Jun 5, 2026 | Christine Zedelmayer | Sale | 14,584 | $2.93 |
| Jun 4, 2026 | Stephen Connelly | Sale | 200,000 | $3.16 |
| Jun 4, 2026 | Stephen Connelly | Sale | 200,000 | $3.16 |
| Jun 4, 2026 | Stephen Connelly | Sale | 200,000 | $3.16 |
| Jun 4, 2026 | Stephen Connelly | Sale | 200,000 | $3.16 |
| May 28, 2026 | Penny Tom | Sale | 65,000 | $2.95 |
| May 28, 2026 | Penny Tom | Sale | 65,000 | $2.95 |
| May 28, 2026 | Penny Tom | Sale | 65,000 | $2.95 |
EQ financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-22.40M | -0.39 | $-22.75M |
| Dec 31, 2024 | $41.09M | $-8.07M | -0.23 | $-19.03M |
| Dec 31, 2023 | $36.08M | $-13.34M | -0.38 | $-21.78M |
| Dec 31, 2022 | $15.76M | $-62.43M | -1.85 | $-8.73M |
| Dec 31, 2021 | — | $-39.05M | -1.36 | $-32.08M |
Latest balance sheet: total assets $58.67M, total liabilities $2.65M, cash $57.16M (as of Jun 30, 2026).
EQ earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $2.01 |
| May 13, 2026 | 8-K Item 2.02 (results) | $2.31 |
| Mar 25, 2026 | 8-K Item 2.02 (results) | $2.06 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $0.84 |
| Aug 4, 2025 | 8-K Item 2.02 (results) | $0.56 |
| Apr 24, 2025 | 8-K Item 2.02 (results) | $0.47 |
| Mar 27, 2025 | 8-K Item 2.02 (results) | $0.49 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $0.78 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| Jul 18, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Mar 25, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on EQ
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.